Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2467${count})

  • Parkin Therapeutic Development, 2014
    Pharmacological Modulation of Parkin Expression and Function to Attenuate Mitochondrial Dysfunction

    Objective/Rationale:
    This project aims to identify drug-like molecules that increase the amount of the protein parkin in neuronal cells. Parkin is mutated in some people with Parkinson’s disease (PD)...

  • Rapid Response Innovation Awards, 2014
    Regulation of Alpha-synucleinopathy by BPOZ-2

    Objective/Rationale:             
    BPOZ-2 is an anti-tumor protein that has been reported to stimulate the removal of cancer- related protein aggregates in cancer cells. However, its role has never been...

  • Rapid Response Innovation Awards, 2014
    siRNA Screen of Microglia to Identify Neuroprotective Drug Targets in Parkinson´s Disease

    Objective/Rationale:             
    Neuroinflammation is a fundamental process contributing to the death of neurons in Parkinson´s disease (PD). During this process, inflammatory microglia, which are the...

  • Rapid Response Innovation Awards, 2014
    Mirtazapine as a Treatment for Pathological Gambling

    Objective/Rationale:             
    Pramipexole (Mirapex®) is a drug that is effective at alleviating movement deficits associated with Parkinson’s disease. However, pramipexole can induce compulsive...

  • Rapid Response Innovation Awards, 2014
    Pum2-mediated Translational Regulation of Alpha-synuclein mRNA Associated with Mitochondria

    Objective/Rationale:             
    Aggregation of the protein alpha-synuclein and dysfunction of mitochondria (the powerhouse of the cell) are two critical components of Parkinson’s disease. We have...

  • Research Grant, 2014
    Bioenergetic and Proteomic Profiling of PINK1, DJ-1 and Parkin Models

    Objective/Rationale:
    Some forms of familial Parkinson’s disease (PD) are due to mutations in the genes that code for the proteins PINK1, DJ-1 and parkin. These proteins have specific roles in the...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.